Average Co-Inventor Count = 4.78
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (12 from 1,454 patents)
2. Rhone-poulenc Rorer S.a. (5 from 247 patents)
3. Aventis Pharma S.a. (3 from 377 patents)
4. Centelion (1 from 13 patents)
5. Rhone-poulenc Biochimie, Et Al. (1 from 1 patent)
6. Rhone Poulenc Biochimie (1 from 1 patent)
23 patents:
1. 10112991 - Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
2. 9815902 - Humanized anti-CXCR5 antibodies, derivatives thereof and their uses
3. 9493529 - Robo1-Fc fusion protein and use thereof for treating tumours
4. 9441040 - Antagonist antibodies and their fab fragments against GPVI and uses thereof
5. 9382312 - Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
6. 9243067 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
7. 9228019 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
8. 9175087 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
9. 8980262 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
10. 8852593 - Antagonist antibodies and their fab fragments against GPVI and uses thereof
11. 8647622 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
12. 8614299 - Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
13. 8119770 - Modified soluble FGF receptor Fc fusions with improved biological activity
14. 7514218 - Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
15. 6656709 - Methods of increasing the production of cobalamins using cob gene expression